As of 2026-08-24, BiomX Inc. (PHGE) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 21. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.7%, relative volume 0.38×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
PHGE is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -48.6% / -95.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PHGE Jan avg: 72.72% median: 49.68% win: 50% σ: 102.22% n: 4 2022-04-12 → 2026-07-31 | PHGE Feb avg: -10.67% median: -13.39% win: 25% σ: 13.19% n: 4 2022-04-12 → 2026-07-31 | PHGE Mar avg: 16.30% median: -12.54% win: 25% σ: 65.56% n: 4 2022-04-12 → 2026-07-31 | PHGE Apr avg: -17.09% median: -11.47% win: 40% σ: 35.17% n: 5 2022-04-12 → 2026-07-31 | PHGE May avg: -1.71% median: -16.49% win: 40% σ: 41.84% n: 5 2022-04-12 → 2026-07-31 | PHGE Jun avg: -17.52% median: -8.16% win: 40% σ: 32.05% n: 5 2022-04-12 → 2026-07-31 | PHGE Jul avg: -10.54% median: -13.44% win: 40% σ: 31.36% n: 5 2022-04-12 → 2026-07-31 | PHGE Aug avg: -12.91% median: -22.84% win: 25% σ: 38.08% n: 4 2022-04-12 → 2026-07-31 (current) | PHGE Sep avg: -17.32% median: -14.20% win: 0% σ: 15.03% n: 4 2022-04-12 → 2026-07-31 | PHGE Oct avg: -10.49% median: -11.66% win: 25% σ: 13.34% n: 4 2022-04-12 → 2026-07-31 | PHGE Nov avg: -23.20% median: -15.74% win: 0% σ: 20.95% n: 4 2022-04-12 → 2026-07-31 | PHGE Dec avg: -20.22% median: -15.95% win: 50% σ: 31.11% n: 4 2022-04-12 → 2026-07-31 |